-
EP3273987
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3273987
| EP3273987 - IN VITRO ARTIFICIAL LYMPH NODE METHOD FOR SENSITIZATION AND EXPANSION OF T CELLS FOR THERAPY AND EPITOPE MAPPING [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 26.06.2020 Database last updated on 15.06.2024 | |
| Former | Examination is in progress Status updated on 29.05.2019 | ||
| Former | Request for examination was made Status updated on 29.12.2017 | ||
| Former | The international publication has been made Status updated on 25.10.2017 | Most recent event Tooltip | 26.06.2020 | Application deemed to be withdrawn | published on 29.07.2020 [2020/31] | Applicant(s) | For all designated states Czerniecki, Brian, J. 77 Chews Landing Road Haddonfield, NJ 08033 / US | [2018/05] | Inventor(s) | 01 /
LOWENFELD, Lea 210 West Rittenhouse Square Philadelphia, PA 19103 / US | 02 /
CZERNIECKI, Brian, J. 905 Harbour Bay Drive Tampa, FL 33602 / US | [2018/17] |
| Former [2018/05] | 01 /
LOWENFELD, Lea 210 West Rittenhouse Square Philadelphia, PA 19103 / US | ||
| 02 /
CZERNIECKI, Brian, J. 77 Chews Landing Road Haddonfield, NJ 08033 / US | Representative(s) | Biggi, Cristina Bugnion S.p.A. Viale Lancetti 17 20158 Milano / IT | [2018/05] | Application number, filing date | 16769839.8 | 28.03.2016 | [2018/05] | WO2016US24540 | Priority number, date | US201562138969P | 26.03.2015 Original published format: US 201562138969 P | [2018/05] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2016154625 | Date: | 29.09.2016 | Language: | EN | [2016/39] | Type: | A1 Application with search report | No.: | EP3273987 | Date: | 31.01.2018 | Language: | EN | The application published by WIPO in one of the EPO official languages on 29.09.2016 takes the place of the publication of the European patent application. | [2018/05] | Search report(s) | International search report - published on: | US | 29.09.2016 | (Supplementary) European search report - dispatched on: | EP | 10.07.2018 | Classification | IPC: | A61K39/00, A61K38/00, C12N5/0783, C12N5/0784 | [2018/05] | CPC: |
C12N5/0636 (EP,US);
A61K39/0011 (US);
A61K39/4611 (EP);
A61K39/4615 (EP);
A61K39/4622 (EP);
A61K39/4631 (EP);
A61K39/464406 (EP);
A61P35/00 (EP);
G01N33/574 (US);
A61K2039/5154 (US);
A61K2039/5158 (US);
A61K2039/55533 (US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/05] | Title | German: | KÜNSTLICHES LYMPHKNOTENVERFAHREN IN VITRO ZUR SENSIBILISIERUNG UND EXPANSION VON T-ZELLEN FÜR THERAPIE UND EPITOPKARTIERUNG | [2018/05] | English: | IN VITRO ARTIFICIAL LYMPH NODE METHOD FOR SENSITIZATION AND EXPANSION OF T CELLS FOR THERAPY AND EPITOPE MAPPING | [2018/05] | French: | MÉTHODE UTILISANT UN GANGLION LYMPHATIQUE ARTIFICIEL IN VITRO POUR LA SENSIBILISATION ET L'EXPANSION DE LYMPHOCYTES T DANS LA THÉRAPIE ET LA CARTOGRAPHIE DES ÉPITOPES | [2018/05] | Entry into regional phase | 25.10.2017 | National basic fee paid | 25.10.2017 | Search fee paid | 25.10.2017 | Designation fee(s) paid | 25.10.2017 | Examination fee paid | Examination procedure | 25.10.2017 | Examination requested [2018/05] | 25.10.2017 | Date on which the examining division has become responsible | 06.02.2019 | Amendment by applicant (claims and/or description) | 04.06.2019 | Despatch of a communication from the examining division (Time limit: M06) | 17.12.2019 | Application deemed to be withdrawn, date of legal effect [2020/31] | 17.01.2020 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2020/31] | Fees paid | Renewal fee | 26.03.2018 | Renewal fee patent year 03 | 27.03.2019 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [Y]US5846538 (CHEEVER MARTIN A [US], et al) [Y] 16* column 13, line 55 - column 14, line 25 *; | [XY]US2011182870 (LEEN ANN M [US], et al) [X] 1-9 * paragraph [0234] * * paragraph [0069] * [Y] 4,6,12,14,15; | [XY]WO2012140127 (IMMUNICUM AB [SE], et al) [X] 1-8 * page 15, line 31 - page 16, line 5; claims 12, 13 * [Y] 4,6,12,14,15; | [XY] - SONIA A PEREZ ET AL, "HER-2/neu-derived peptide 884-899 is expressed by human breast, colorectal and pancreatic adenocarcinomas and is recognized by in-vitro-induced specific CD4+ T cell clones", CANCER IMMUNOLOGY, IMMUNOTHE, SPRINGER, BERLIN/HEIDELBERG, vol. 50, no. 11, doi:10.1007/S002620100225, ISSN 0340-7004, (20020101), pages 615 - 624, (20011123), XP009138053 [X] 1-3,5,7-11,13 * page 617, column r, paragraph 3 * [Y] 4,6,12,14,15 DOI: http://dx.doi.org/10.1007/s002620100225 | [XY] - SOTIRIADOU R ET AL, "Peptide HER2(776-788) represents a naturally processed broad MHC class II-restricted T cell epitope", BRITISH JOURNAL OF CANCER, NATURE PUBLISHING GROUP, GB, (20011116), vol. 85, no. 10, doi:10.1054/BJOC.2001.2089, ISSN 0007-0920, pages 1527 - 1534, XP002293865 [X] 1-3,5,7-11,13 * page 1529, column l, paragraph 3 * [Y] 4,6,12,14-16 DOI: http://dx.doi.org/10.1054/bjoc.2001.2089 | International search | [A]US2013078270 (CHO HELEN KIM [US], et al) [A] 1-16 * entire document *; | [Y] - SCHLIENGER et al., "Efficient priming of protein antigen-specific human CD 4+ T cells by monocyte-derived dendritic cells", Blood, (20001115), vol. 96, pages 3490 - 8, XP000985928 [Y] 1-5, 8-13, 16 * . entire document * | [Y] - CZERNIECKI et al., "Targeting HER-2/neu in early breast cancer development using dendritic cells with staged interleukin-12 burst secretion", Cancer Res., (20070209), vol. 67, no. 4, pages 1842 - 52, XP055269484 [Y] 1-5, 8-13, 16 * . entire document * DOI: http://dx.doi.org/10.1158/0008-5472.CAN-06-4038 | [Y] - MACLEOD et al., "Memory CD 4 T cells: generation, reactivation and re-assignment", Immunology, (20100316), vol. 130, no. 1, pages 10 - 5, XP055318770 [Y] 4, 12 * . entire document * DOI: http://dx.doi.org/10.1111/j.1365-2567.2010.03260.x | [A] - FRACOL et al., "Response to HER-2 pulsed DC1 vaccines is predicted by both HER-2 and estrogen receptor expression in DCIS", Ann Surg Oncol., (20130713), vol. 20, no. 10, pages 3233 - 9, XP055318772 [A] 1-16 * . entire document * DOI: http://dx.doi.org/10.1245/s10434-013-3119-y |